417 related articles for article (PubMed ID: 15343189)
1. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
[TBL] [Abstract][Full Text] [Related]
2. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
Greenway A; Ware RE; Thornburg CD
Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
[TBL] [Abstract][Full Text] [Related]
4. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE;
Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
6. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease.
Ware RE; Zimmerman SA; Schultz WH
Blood; 1999 Nov; 94(9):3022-6. PubMed ID: 10556185
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
DeBaun MR
J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052
[No Abstract] [Full Text] [Related]
9. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
Ware RE; Schultz WH; Yovetich N; Mortier NA; Alvarez O; Hilliard L; Iyer RV; Miller ST; Rogers ZR; Scott JP; Waclawiw M; Helms RW
Pediatr Blood Cancer; 2011 Dec; 57(6):1011-7. PubMed ID: 21826782
[TBL] [Abstract][Full Text] [Related]
10. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
11. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).
Ware RE; Helms RW;
Blood; 2012 Apr; 119(17):3925-32. PubMed ID: 22318199
[TBL] [Abstract][Full Text] [Related]
12. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload.
Aygun B; Mortier NA; Kesler K; Lockhart A; Schultz WH; Cohen AR; Alvarez O; Rogers ZR; Kwiatkowski JL; Miller ST; Sylvestre P; Iyer R; Lane PA; Ware RE;
Br J Haematol; 2015 Apr; 169(2):262-6. PubMed ID: 25612463
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
16. Optimizing hydroxyurea therapy for sickle cell anemia.
Ware RE
Hematology Am Soc Hematol Educ Program; 2015; 2015():436-43. PubMed ID: 26637755
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
Anderson N
Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.
Altura RA; Wang WC; Wynn L; Altura BM; Altura BT
J Pediatr; 2002 May; 140(5):565-9. PubMed ID: 12032523
[TBL] [Abstract][Full Text] [Related]
19. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial.
Wood JC; Cohen AR; Pressel SL; Aygun B; Imran H; Luchtman-Jones L; Thompson AA; Fuh B; Schultz WH; Davis BR; Ware RE;
Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
Al-Jam'a AH; Al-Dabbous IA
Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
